Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Dyadic International (DYAI)

Dyadic International (DYAI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 173,239
  • Shares Outstanding, K 27,111
  • Annual Sales, $ 760 K
  • Annual Income, $ -2,140 K
  • 60-Month Beta 0.19
  • Price/Sales 98.99
  • Price/Cash Flow N/A
  • Price/Book 4.50

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.07
  • Number of Estimates 1
  • High Estimate -0.07
  • Low Estimate -0.07
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.01%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.50 +16.18%
on 09/16/19
6.70 -4.63%
on 10/07/19
+0.84 (+15.14%)
since 09/13/19
3-Month
4.75 +34.53%
on 07/16/19
6.90 -7.39%
on 08/22/19
+0.76 (+13.50%)
since 07/12/19
52-Week
1.55 +312.26%
on 10/29/18
7.30 -12.47%
on 06/19/19
+4.38 (+217.12%)
since 10/12/18

Most Recent Stories

More News
Dyadic to Attend Three Upcoming Investor Conferences in October

JUPITER, FL / ACCESSWIRE / October 10, 2019 / Dyadic International, Inc. (the "Company") (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene...

DYAI : 6.39 (-1.69%)
Dyadic to Present at Janney Healthcare Conference

JUPITER, FL / ACCESSWIRE / September 4, 2019 / Dyadic International, Inc. (the "Company") (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene...

DYAI : 6.39 (-1.69%)
Dyadic to Present at Four Upcoming Investor Conferences in September

JUPITER, FL / ACCESSWIRE / August 21, 2019 / Dyadic International, Inc. (the "Company") (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression...

DYAI : 6.39 (-1.69%)
Dyadic Reports Second Quarter 2019 Results and Recent Developments

Dyadic International, Inc. ("Dyadic") (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to accelerate development, lower...

FSNN : 0.0580 (-19.44%)
DYAI : 6.39 (-1.69%)
Dyadic to Report Second Quarter 2019 Financial Results on Tuesday August 13, 2019

JUPITER, FL / ACCESSWIRE / July 30, 2019 / Dyadic International, Inc. ("Dyadic") (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression...

DYAI : 6.39 (-1.69%)
OTC Markets Group Announces Quarterly Index Performance and Rebalancing

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the second quarter 2019 performance and quarterly rebalancing of the OTCQX® and...

DYAI : 6.39 (-1.69%)
FDMQY : 0.5200 (-14.75%)
BBXTB : 4.2500 (-6.59%)
DUOT : 0.5100 (+8.51%)
IEHC : 20.5000 (+0.49%)
ACRGF : 5.8800 (+1.38%)
SMICY : 6.2500 (-0.45%)
CBBI : 10.6000 (-0.47%)
CBWA : 13.7000 (+1.03%)
CTUY : 29.7500 (-4.03%)
DBIN : 32.2500 (+0.47%)
ENBP : 20.3500 (-1.21%)
FNBT : 25.0500 (unch)
IBTN : 16.0800 (+0.06%)
KTYB : 23.3000 (+0.43%)
LYBC : 39.2500 (+0.64%)
MNMB : 40.3000 (+1.13%)
PFLC : 11.4000 (unch)
RYFL : 16.3000 (+0.31%)
SVBT : 79.7400 (+0.29%)
WRIV : 66.3000 (+0.08%)
AMXEF : 0.7300 (-11.24%)
CTSDF : 0.7243 (+0.60%)
AGEEF : 0.2170 (+11.28%)
HERTF : 0.1810 (+3.19%)
MEDIF : 2.9800 (+1.71%)
NXGWF : 0.1510 (+18.62%)
PLNHF : 1.6200 (-1.82%)
RDDTF : 0.3740 (-0.03%)
ALXDF : 0.0398 (-0.50%)
DYMEF : 0.0680 (-4.23%)
OTCM : 35.7200 (+0.62%)
Dyadic Extends Research and Development Agreement with VTT

JUPITER, FLORIDA / ACCESSWIRE / July 5, 2019 / Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ: DYAI), a global platform biotechnology company, announced today that it has extended its research...

DYAI : 6.39 (-1.69%)
Dyadic Joins Russell Microcap(R) Index

JUPITER, FL / ACCESSWIRE / July 2, 2019 / Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary...

DYAI : 6.39 (-1.69%)
Dyadic Announces Appointment of Ping Rawson to CFO

JUPITER, FL / ACCESSWIRE / June 27, 2019 / Dyadic International, Inc. ("Dyadic") (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression...

DYAI : 6.39 (-1.69%)
Dyadic to Present at the 20th Annual B. Riley FBR Investor Conference and Upcoming Industry Events

JUPITER, FL / ACCESSWIRE / May 17, 2019 / Dyadic International, Inc. (the ''Company'') (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression...

DYAI : 6.39 (-1.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Good. Long term indicators fully support a continuation of the trend.

See More Share

Trade DYAI with:

Business Summary

Dyadic International, Inc. is a leading genomics company with the groundbreaking technology that brings nature to the marketplace. Dyadic is poised to become a global leader in proteomics through the discovery, development, and manufacturing of novel products derived from the DNA of complex living organisms...

See More

Key Turning Points

2nd Resistance Point 6.72
1st Resistance Point 6.56
Last Price 6.39
1st Support Level 6.28
2nd Support Level 6.16

See More

52-Week High 7.30
Last Price 6.39
Fibonacci 61.8% 5.10
Fibonacci 50% 4.43
Fibonacci 38.2% 3.75
52-Week Low 1.55

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar